Focusing on IVD sector, we provide trustworthy quality products and professional services to domestic and international customers
Published on: March 20, 2018
The 15th China Association of Clinical Laboratory Practice Expo was held in Chongqing on March 17-19, 2018, together with 5th Bode China (International) In-Vitro Diagnostics Forum (BFIVD) and 3rd China Experimental Medicine Conference (CEMC). The Exhibition attracted about 800 exhibitors and twenty thousands of visitors.
As the Vice President Unit of Chinese Association of In-Vitro Diagnostics (CAIVD), Runda Medical was invited to the opening ceremony of the expo and participated in ribbon cutting event together with The National Medical and Health Management Departments, National Association of Health Industry as well as the leaders from a variety of industrial associations.
With the theme of “Innovative Concept, Excellent Technology, Improvement in Care”, Runda Medical displayed a full range of own brand products, including clinical chemistry and PCR reagents, POCT, A1C systems, 3rd party QC solution, lab-management IT platform, automated chemiluminescence system and CLINILOG-RD, which is an open LAS under strategic collaboration with A&T Corporation.
The own brand product series from Runda Medical drawn highly attention
As a comprehensive service provider, own brand development is also a key focus of us in order to provide various local medical solutions that based on market demands. As the total laboratory automation need is on a rise, open LAS allows users to be more flexibly in choosing lab devices to meet personalized requirements for better efficiency and quality improvement. During the exhibition, Runda Medical invited Mr. Uchidah, the Permanent Representative of A&T Corporation (Japan) gave product presentation of CLINILOG-RD, the first fully open LAS in China market and received enthusiastic responses from audiences.
Overwhelming responses to the presentation of CLINILOG-RD
This was the first time for Runda Medical to present entire own brand product series, and gained extensive attention of partners and peers. With a commitment of “constantly innovate and continuously optimize”, we will develop more medical diagnostics solutions in line with national conditions, and make contribution to the goal of Healthy China.